These results are in agreement with findings demonstrating reduced PPARG expression in inflamed skin lesions 10, 12, 14 and with the beneficial effects of PPARγ ligands in patients with psoriasis and in a murine model of this disease.4, 26. This evidence concerns the gene PPARG and psoriasis.